Does price deregulation increase drug price in China? An interrupted time series analysis

Autor:	Judy Xu, Yao Xiong, Yuexia Gao
Rok vydání:	2021
Předmět:	China Government 030503 health policy & services Health Policy Interrupted time series Interrupted Time Series Analysis Monetary economics Drug Costs Price ceiling 03 medical and health sciences Deregulation Pharmaceutical Preparations Price index Costs and Cost Analysis Economics Consumer price index 0305 other medical science health care economics and organizations
Zdroj:	The International Journal of Health Planning and Management. 36:1653-1665
ISSN:	1099-1751 0749-6753
DOI:	10.1002/hpm.3244
Popis:	BACKGROUND The Chinese government removed the price ceiling of most drugs in June 2015 to establish a market-driven pricing system. The purpose of this study is to examine the impact of the elimination of drug ceiling price (EDCP) policy on drug prices. METHODS Using a national macro-level dataset, we employed an interrupted time series method to study the abrupt level and gradual trend changes of Chinese and Western medicine consumer price index (CPI) between June 2014 and June 2017. RESULTS The policy exerted level change on Chinese medicine CPI, increasing 0.201% (95% CI 0.026% to 0.376%, p = 0.026). And the trend in Chinese medicine CPI was still decreased nonsignificantly after the EDCP policy. However, there was no significant price change in Western medicine. CONCLUSION The EDCP policy has different effects on the prices of Chinese and Western medicines. Therefore, we need to pay more attention to the drug pricing mechanism in the future.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2201c6a5394df0099d2de38ea9e036b2 https://doi.org/10.1002/hpm.3244 Zobrazit plný text záznamu Plný text ve formátu PDF Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.